AZN

AstraZeneca PLC (AZN)

Last Price$74.20.9%

Market Cap$460.2B

LTM Operating Income margin

18.5%

5Y avg

12.6%

Drug Manufacturers - General industry median

20.3%

Stock quality & Intrinsic value

7/10

(0.6%) overvalued

is (60.2%) overvalued

undervalued stocks

Start beating the S&P 500

AstraZeneca PLC Operating Income margin

Annual

Quarterly

LTM

Industry median

Company stand-alone

AZN

Healthcare

Crunching data... Almost there!

	Dec'04	Dec'05	Dec'06	Dec'07	Dec'08	Dec'09	Dec'10	Dec'11	Dec'12	Dec'13	Dec'14	Dec'15	Dec'16	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23
Operating Income margin	21.2%	27.1%	31.0%	27.4%	28.9%	35.2%	34.5%	38.1%	29.1%	14.4%	8.2%	16.7%	21.3%	16.4%	15.3%	12.0%	19.4%	2.8%	8.5%	17.9%

AZN

Key metrics and insights to make informed decisions.

View full analysis

Overvalued or undervalued?

Check the intrinsic value for AZN and see if it's the right time to invest.

AstraZeneca PLC (AZN) Operating Income margin comparison analysis

Crunching data... Almost there!

AZN key stats

USD

Millions

Billions

Annual

Quarterly

Trailing

Key stats

Income statement

Balance sheet

Cash Flow Statement

Valuation

Ratios

Per share

Per employee

Dividends & Yields

Crunching data... Almost there!

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%

S&P Outperformance 19.1%

Next 3M Predicted Return 20.3%

Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%

S&P Outperformance 22.3%

Next 3M Predicted Return 26.8%

Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.

3M Return 28.4%

S&P Outperformance 15.4%

Next 3M Predicted Return 16.9%

FAQ

1) What is AstraZeneca PLC's Operating Income margin?

As of today, Microsoft Corp's last 12-month Operating Income margin is 18.5%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Operating Income margin for AstraZeneca PLC have been 11.2% over the past three years, and 13.2% over the past five years.

2) Is AstraZeneca PLC's Operating Income margin Good?

As of today, AstraZeneca PLC's Operating Income margin is 18.5%, which is lower than industry median of 20.3%. It indicates that AstraZeneca PLC's Operating Income margin is Bad.

3) How does AstraZeneca PLC's Operating Income margin compare to its peers?

As of today, AstraZeneca PLC's Operating Income margin is 18.5%, which is lower than peer median of 22.4%. The list of peers includes LLY, MRK, GILD, NVS, PFE, AMGN, JNJ, BMY, SNY, ABBV.